By Selma OransayDienogest versus combined oral contraceptives treatment in postoperative endometriosis care
By Selma Oransay
Dienogest is a synthetic progestin derivative, like oral contraceptives, used to prevent endometriosis recurrence after surgery. Randomized clinical trials verified a significantly higher reduction in endometriotic lesions, clinical symptoms, and improved quality of life obtained when dienogest was given to…
Key Points Lay Summary
The cost-effectiveness of different GnRH agonist regimes for progestogen-resistant endometriosis.
By Selma Oransay
Surgical and medical treatments are currently used to treat the pelvic pain caused by endometriosis. Respected guidelines recommend using progestins with or without estrogens as first-line medical treatment due to their safety, effectiveness, inexpensive, and tolerability. However, one-third to one-quarter…
Key Points Lay Summary
By Bahar YukselEconomic burden while living with endometriosis.
By Bahar Yuksel
Endometriosis is a debilitating disease when all the symptoms are considered. Besides mental and physical effects, the economic burden is also a problem for the patients. In the study conducted by Josep Darbà et al, the costs of endometriosis have…
Key Points Lay Summary
By Özge ÖzkayaThe Cost of Healthcare for Chronic Pelvic Pain
By Özge Özkaya
The healthcare costs of pelvic pain range between 1,367 USD and 7,043 USD per woman per year, found a new study published in the Journal of Obstetrics and Gynaecology Canada. The study also reported that prescription costs ranged between 193…
Key Points Lay Summary
By Hale Goksever CelikFertility preservation protocols in women with endometriosis
By Hale Goksever Celik
Infertility is one of the major symptoms in women with endometriosis. Childbearing at a delayed age is preferred by the majority of women recently who consult for the demand for fertility preservation procedures. There are several techniques for fertility preservation…
Key Points Lay Summary
Health care resource utilization and cost in women with endometriosis
By Hale Goksever Celik
Endometriosis is a chronic inflammatory disease affecting 6-10% of reproductive-aged women. The clinical picture of the disease range from asymptomatic findings to dysmenorrhea, dyspareunia, chronic pelvic pain, and infertility. Endometriosis has also complex etiopathogenetic background. This broad clinical spectrum, the…
Key Points Lay Summary
Best endometriosis articles of the past year.
By Selma Oransay
Dr.Stowall, from the Department of Obstetrics and Gynecology of Methodist Hospital, Dallas, Texas, USA penned this letter and recently published it in the Journal of Obstetrics and Gynecology to show his remarks of importance on four best publications of the…
Key Points Lay Summary
By Nasuhi Engin AydinThoracic Endometriosis Syndrome (TES): Diagnosis by cytology of pleural effusion
By Nasuhi Engin Aydin
Parikshaa Gupta and colleagues from Chandigarh, India report a case of thoracic endometriosis diagnosed primarily by pleural fluid cytology in a most recent article at Cytopathology. A 33-year-old female presented with a long history of recurrent bouts of chest pain…
Key Points Lay Summary
Oral Contraceptives and Low-Cost Progestins to Reduce Endometriosis-Associated Pain
By Özge Özkaya
Most women with endometriosis-associated pain did not feel the need to use expensive progestin or undergo surgery. Instead, they were satisfied with a low-cost progestin to treat their symptoms. This is according to a study published in the journal Fertility…
Key Points Lay Summary
Endometriosis Costs the Economy Almost $15,000 a Year per Patient
By Özge Özkaya
Patients with endometriosis incur significantly higher healthcare costs compared to other patients, a found a study published in the scientific journal Advances in Therapy. Because over 10 million women in the U.S. and an estimated 200 million women worldwide have…
Key Points Lay Summary
By Kasthuri NairHow to Minimize the Costs Associated with Endometriosis Care
By Kasthuri Nair
Paolo Vercellini, Maria Pina Frattaruolo and Laura Buggio, from Milan, Italy, recently published an editorial titled “Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment” in Expert Review of Pharmacoeconomics & Outcomes Research. The…
Key Points Lay Summary
The Most Cost Effective Medical Treatment to Prevent Recurrent Endometriosis
By Özge Özkaya
A new study conducted in China found that a class of drugs called Gonadotropin-releasing hormone agonists (GnRH-a) is more cost effective for the treatment of recurrent endometriosis despite the fact that they are more expensive than oral contraceptives. The results…
Key Points Lay Summary